drugset / Trial / NCT05518812
Carboprost (Hemabate) for Fibroid Resection
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this research study is to determine if low-dose (i.e., a fraction of what is commonly used) carboprost (Hemabate) helps facilitate fibroid removal (myomectomy).
Timeline
- Start
- 2022-07-12
- Primary completion
- 2024-05-06
- Completion
- 2024-05-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboprost Tromethamine | Unknown | 10 ug/ml | Other |